Top

Published in:

01-06-2009 | Review

Functional Consequences of HIV-Associated Neuropsychological Impairment

Authors: Ashley A. Gorman, Jessica M. Foley, Mark L. Ettenhofer, Charles H. Hinkin, Wilfred G. van Gorp

Published in: Neuropsychology Review | Issue 2/2009

Abstract

This review focuses on the “real world” implications of infection with HIV/AIDS from a neuropsychological perspective. Relevant literature is reviewed which examines the relationships between HIV-associated neuropsychological impairment and employment, driving, medication adherence, mood, fatigue, and interpersonal functioning. Specifically, the relative contributions of medical, cognitive, psychosocial, and psychiatric issues on whether someone with HIV/AIDS will be able to return to work, adhere to a complicated medication regimen, or safely drive a vehicle will be discussed. Methodological issues that arise in the context of measuring medication adherence or driving capacity are also explored. Finally, the impact of HIV/AIDS on mood state, fatigue, and interpersonal relationships are addressed, with particular emphasis on how these variables interact with cognition and independent functioning. The purpose of this review is to integrate neuropsychological findings with their real world correlates of functional behavior in the HIV/AIDS population.

Albert, S. M., Marder, K., Dooneief, G., Bell, K., Sano, M., Todak, G., et al. (1995). Neuropsychological impairment in early HIV infection: a risk factor for work disability. Archives of Neurology, 52, 525–530.PubMed

Albert, S. M., Weber, C. M., Todak, G., Polanco, C., Clouse, R., McElhiney, M., et al. (1999). An observed performance test of medication management ability in HIV: relation to neuropsychological status and medication adherence outcomes. AIDS and Behavior, 3(2), 121–128.

Ances, B. M., & Ellis, R. J. (2007). Dementia and neurocognitive disorders due to HIV-1 infection. Seminars in Neurology, 27(1), 86–92.PubMed

Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., et al. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33(8), 1417–1423.PubMed

Atkinson, J. H., Grant, I., Kennedy, C. J., Richman, D. D., Spector, S. A., & McCutchan, J. A. (1988). Prevalence of psychiatric disorders among men infected with human immunodeficiency virus: a controlled study. Archives of General Psychiatry, 45(9), 859–864.PubMed

Baldeweg, T., Catalan, J., & Gazzard, B. G. (1998). Risk of HIV dementia and opportunistic brain disease in AIDS and zidovudine therapy. Journal of Neurology, Neurosurgery and Psychiatry, 65(1), 34–41.

Bangsberg, D. R. (2006). Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: The past, the present, and the future. AIDS Behavior, 10(3), 249–251.

Barclay, T. R., Hinkin, C. H., Castellon, S. A., Mason, K. I., Reinhard, M. J., Marion, S. D., et al. (2007). Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychology, 26(1), 40–49.PubMed

Bartels, A. L., Kortekaas, R., Bart, J., Willemsen, A. T., de Klerk, O. L., de Vries, J. J., et al. (2008). Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration. Neurobiology of Aging.

Basu, S., Chwastiak, L. A., & Bruce, R. D. (2005). Clinical management of depression and anxiety in HIV-infected adults. AIDS, 19, 2057–2067.PubMed

Becker, J. T., Lopez, O. L., Dew, M. A., Aizenstein, H. J., & Suppl 1. (2004). Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS, 18, S11–18.PubMed

Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58(8), 721–728.PubMed

Blalock, A., McDaniel, S., & Farber, E. (2002). Effect of employment on quality of life and psychological functioning in patients with HIV/AIDS. Psychosomatics, 43, 400–404.PubMed

Bottiggi, K. A., Chang, J. J., Schmitt, F. A., Avison, M. J., Mootoor, Y., Nath, A., et al. (2007). The HIV dementia scale: predictive power in mild dementia and HAART. Journal of the Neurological Sciences, 260, 11–15.PubMed

Brew, B. J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18, S75–S78.PubMed

Brooks, R. A., Ortiz, D. J., Veniegas, R., Martin, D. (1999). Employment issues survey: findings from a survey of employment issues affecting persons with HIV/AIDS living in Los Angeles County—final report. Office of the Los Angeles City AIDS Coordinator.

Brouwer, W., Waterink, W., Van Wolffelaar, P., & Rothengatter, T. (1991). Divided attention in experienced young and older drivers: lane tracking and visual analysis in a dynamic driving simulator. Human Factors, 33(5), 573–582.PubMed

Brouwers, P., Hendricks, M., Lietzau, J. A., Pluda, J. M., Mitsuya, H., Broder, S., et al. (1997). Effect of combination therapy with zidovudine and didanosine on neuropsychological functioning in patients with symptomatic HIV disease: a comparison of simultaneous and alternating regimens. AIDS, 11(1), 59–66.PubMed

Buckner, R. L. (2004). Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron, 44(1), 195–208.PubMed

Burgoyne, R. W. (2005). Exploring direction of causation between social support and clinical outcome for HIV-positive adults in the context of highly active antiretroviral therapy. AIDS Care, 17, 111–124.PubMed

Carney, R. M., Freedland, K. E., Eisen, S. A., Rich, M. W., & Jaffe, A. S. (1995). Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology, 14(1), 88–90.PubMed

Castellon, S. A., Hinkin, C. H., & Myers, H. (2001). Neuropsychiatric alterations and neurocognitive performance in HIV/AIDS: a response to C. Bungener and R. Jouvent. Journal of the International Neuropsychological Society, 7, 776–777.

Castellon, S. A., Hinkin, C. H., Wood, S., & Yarema, K. T. (1998). Apathy, depression, and cognitive performance in HIV-1 infection. Journal of Neuropsychiatry, 10(3), 320–329.

Castellon, S. A., Myers, H., & Hinkin, C. H. (2000). Neuropsychiatric disturbance is associated with executive dysfunction in HIV-infection. Journal of the International Neuropsychological Society, 6, 336–347.PubMed

Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19(2), 124–133.PubMed

Centers for Disease Control and Prevention. (2007). HIV/AIDS Surveillance Report, 2005. (Vol. 17). Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.

Chandra, P. S., Desai, G., & Ranjan, S. (2005). HIV and psychiatric disorders. The Indian Journal of Medical Research, 121, 451–467.PubMed

Ciesla, J. A., & Roberts, J. E. (2001). Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry, 158(5), 725–730.PubMed

Clarke, D. E., van Reekum, R., Simard, M., Streiner, D. L., Conn, D., Cohen, T., et al. (2008). Apathy in dementia: clinical and sociodemographic correlates. The Journal of Neuropsychiatry and Clinical Neurosciences, 20(3), 337–347.PubMed

Clerici, M., Seminari, E., Maggiolo, F., Pan, A., Migliorino, M., Trabattoni, D., et al. (2002). Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients. AIDS, 16(13), 1767–1773.PubMed

Cole, M. A., Castellon, S. A., Perkins, A. C., Ureno, O. S., Robinet, M. B., Reinhard, M. J., et al. (2007). Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals. Journal of the International Neuropsychological Society, 13, 549–554.PubMed

Deschamps, A. E., Graeve, V. D., van Wijngaerden, E., De Saar, V., Vandamme, A. M., van Vaerenbergh, K., et al. (2004). Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using medication event monitoring system. AIDS, Patient Care, and STDS, 18(11), 644–657.

DiClementi, J. D., Ross, M. K., Mallo, C., & Johnson, S. C. (2004). Predictors of successful return to work from HIV-related disability. Journal of HIV/AIDS & Social Services, 3(3), 89–96.

Dray-Spira, R., Gueguen, A., Vespa Study Group, & 2. (2008). Disease severity, self-reported experience of workplace discrimination and employment loss during the course of chronic HIV disease: differences according to gender and education. Occupational and Environmental Medicine, 65, 112–119.PubMed

Edinger, J. D., Carwille, S., Miller, P., Hope, V., & Mayti, C. (1994). Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnea. Perceptual and Motor Skills, 78, 1116–1118.PubMed

Ettenhofer, M. L., Hinkin, C. H., Castellon, S. A., Durvasula, R., Ullman, J., Lam, M., et al. (2009). Aging, neurocognition, and medication adherence in HIV infection. American Journal of Geriatric Psychiatry.

Ferrando, S., Evans, S., Goddin, K., Sewell, M., Fishman, B., & Rabkin, J. (1998). Fatigue in HIV illness: relationship to depression, physical limitations, and disability. Psychosomatic Medicine, 60(6), 759–764.PubMed

Ferrier, S. E., & Lavis, J. N. (2003). With health comes work? People living with HIV/AIDS consider returning to work. AIDS CARE, 15(3), 423–435.PubMed

Fitten, L. J., Perryman, K. M., Wilkinson, C. J., Little, R. J., Burns, M. M., Pachana, N., et al. (1995). Alzheimer and vascular dementias and driving: A prospective road and laboratory study. JAMA, 273, 1360–1365.PubMed

Folkman, S., Chesney, M. A., Pollack, L., & Phillips, C. (1992). Stress, coping, and high-risk sexual behavior. Health Psychology, 11, 218–222.PubMed

Friedland, J., Renwick, R., & McColl, M. (1996). Coping and social support as determinants of quality of life in HIV/AIDS. AIDS Care, 8, 15–31.PubMed

Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of the Acquired Immune Deficiency Syndrome, 23(5), 386–395.

Gooding, A. L., Foley, J., Jang, J., Castellon, S. A., Sadek, J., Heaton, R. K., et al. (2008). Visuospatial and attentional abilities predict driving simulator performance among older HIV-infected adults [Abstract]. The Clinical Neuropsychologist, 22, 402.

Grant, I., Olshen, R. A., Atkinson, J. H., Heaton, R. K., Nelson, J., McCuthchan, J. A., et al. (1993). Depressed mood does not explain neuropsychological deficits in HIV-infected persons. Neuropsychology, 7, 53–61.

Grassi, L., Righi, R., Makoui, S., Sighinolfi, L., Ferri, S., & Ghinelli, F. (1999). Illness behavior, emotional stress, and psychosocial factors among asymptomatic HIV-infected patients. Psychotherapy and Psychosomatics, 68, 31–38.PubMed

Halkitis, P., Palamar, J., & Mukherjee, P. (2008). Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling. AIDS, Patient Care, and STDS, 22(4), 323–335.

Harris, Y., Gorelick, P. B., Cohen, D., Dollear, W., Forman, H., & Fields, S. (1994). Psychiatric symptoms in dementia associated with stroke: a case–control analysis among predominantly African-American patients. Journal of the National Medical Association, 86, 697–702.PubMed

Heaton, R. K., Chelune, G. J., & Lehman, R. A. (1978). Using neuropsychological and personality tests to assess the likelihood of patient employment. The Journal of Nervous and Mental Disease, 166(6), 408–416.PubMed

Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J., Moore, D. J., Bentley, H., et al. (2004). The impact of HIV-associated neuropsychological impairment on everyday functioning. Journal of the International Neuropsychological Society, 10(3), 317–331.PubMed

Heaton, R. K., Velin, R. A., McCutchan, A., et al. (1994). Neuropsychological impairment in human immunodeficiency virus-infection: Implications for employment. Psychosomatic Medicine, 56, 8–17.PubMed

Hinkin, C. H., van Gorp, W. G., Satz, P., Weisman, J., Thommes, J., & Buckingham, S. (1992). Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. Journal of Clinical and Experimental Neuropsychology, 14, 289–297.PubMed

Hinkin, C. H., Van Gorp, W. G., & Satz, P. (1995). Neuropsychological and neuropsychiatric aspects of HIV infection in adults. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry/VI (pp. 1669–1680). Baltimore: Williams & Wilkins.

Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., et al. (2002a). Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 1944–1950.

Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Lam, M. N., Stefaniak, M., et al. (2002b). Verbal and spatial working memory performance among HIV-infected adults. Journal of the International Neuropsychological Society, 8(4), 532–538.

Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. N., et al. (2004). Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS, 18(Suppl 1), S19–25.PubMed

Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., et al. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS Behavior, 11(2), 185–194.

Humphrey, T. (2004). N.O.D./Harris survey. New York: Harris Interactive Inc. 2004.

Johnson, J. G., Rabkin, J. G., Lipsitz, J. D., Williams, J. B., & Remien, R. H. (1999). Recurrent major depressive disorder among human immunodeficiency virus (HIV)-positive and HIV-negative intravenous drug users: findings of a 3-year longitudinal study. Comprehensive Psychiatry, 40(1), 31–34.PubMed

Kalechstein, A. D., Newton, T. F., & van Gorp, W. G. (2003). Neurocognitive functioning is associated with employment status: A quantitative review. Journal of Clinical and Experimental Neuorpsychology, 25(8), 1186–1191.

Kelly, B., Raphael, B., Judd, F., Perdices, M., Kernutt, G., Burnett, P., et al. (1998). Suicidal ideation, suicidal attempts, and HIV infection. Psychosomatics, 39, 405–415.PubMed

Knowlton, A., Hua, W., & Latkin, C. (2004). Social support among HIV-positive injection drug users: implications to integrated intervention for HIV-positives. AIDS and Behavior, 8, 357–363.PubMed

Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 9(3), 179–186.PubMed

Lee, H., Cameron, D., & Lee, A. (2003a). Assessing the driving performance of older adult drivers: on-road versus simulated driving. Accident Analysis and Prevention, 35, 797–803.

Lee, H., Lee, A., Cameron, D., & Li-Tsang, C. (2003b). Using a driving simulator to identify older drivers at inflated risk of motor vehicle crashes. Journal of Safety Research, 34, 453–459.

Lee, H., Lee, A., & Cameron, D. (2003c). Validation of a driving simulator by measuring the visual attention skill of older adult drivers. American Journal of Occupational Therapy, 57(3), 324–328.

Lem, M., Moore, D., Marion, S., Bonner, S., Chan, K., O’Connell, J., et al. (1995). Back to work: Correlates of employment among persons receiving highly active antiretroviral therapy. AIDS Care, 17(6), 740–746.

Levine, A. J., Hardy, D. J., Miller, E., Castellon, S. A., Longshore, D., & Hinkin, C. H. (2006a). The effect of recent stimulant use on sustained attention in HIV-infected adults. Journal of Clinical and Experimental Neuropsychology, 28(1), 29–42.

Levine, A. J., Hinkin, C. H., Marion, S., Keuning, A., Castellon, S. A., Lam, M. M., et al. (2006b). Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Health Psychology, 25(3), 329–335.

Levy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., et al. (1998). Apathy is not depression. Journal of Neuropsychiatry and Clinical Neurosciences, 10, 314–319.PubMed

Lowenstein, D. A., & Bates, B. C. (1992). Manual for administration and scoring the Direct Assessment of Functional Status scale for older adults (DAFS). Miami Beach, FL: Mount Sinai Medical Center.

Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134(10), 968–977.PubMed

Lyketsos, C. G., Hoover, D. R., Guccione, M., Dew, M. A., Wesch, J. E., Bing, E. G., et al. (1996). Changes in depression symptoms as AIDS develops. American Journal of Psychiatry, 153, 1430–1437.PubMed

Mapou, R. L., Law, W. A., Martin, A., Kampen, D., Salazar, A. M., & Rundell, J. R. (1993). Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 86–93.PubMed

Marcotte, T. D., Heaton, R. K., Wolfson, T., Taylor, M. J., Alhassoon, O., Arfaa, K., et al. (1999). The impact of HIV-related neuropsychological dysfunction on driving behavior. JINS, 5, 579–592.PubMed

Marcotte, T., Heaton, R., Reicks, C., Gonzalez, R., Grant, I., et al. (2000). HIV-related neuropsychological impairment and automobile driving. 28th annual INS-Conference.

Marcotte, T., Heaton, R., Gonzalez, R., Reicks, C., & Grant, I. (2001). Assessing driving abilities in HIV-infected individuals with mild NP impairment [abstract]. JINS, 7(2), 230.

Marcotte, T. D., Wolfson, T., Rosenthal, T. J., Marcotte, T. D., Wolfson, T., Rosenthal, T. J., et al. (2004). A multimodal assessment of driving performance in HIV infection. Neurology, 63, 1417–1422.PubMed

Marcotte, T. D., Lazzaretto, D., Scott, J. C., Roberts, E., Woods, S. P., Letendre, S., et al. (2006). Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. Journal of Clinical and Experimental Neuropsychology, 28, 13–28.PubMed

Marin, R. S., Firinciogullari, S., & Biedrzycki, R. C. (1994). Group differences in the relationship between apathy and depression. Journal of Nervous and Mental Disease, 182, 235–239.PubMed

Martin, D. J., Brooks, R. A., Ortiz, D. J., & Veniegas, R. C. (2003). Perceived employment barriers and their relation to workforce entry intent among people with HIV/AIDS. Journal of Occupational Health Psychology, 8(3), 181–194.PubMed

Martin, E. M., Pitrak, D. L., Novak, R. M., Pursell, K. J., & Mullane, K. M. (1999). Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report. Journal of Clinical and Experimental Neuropsychology, 21(5), 730–735.PubMed

McElhiney, M., Rabkin, J.G., Ferrando, S., & van Gorp, W. (2000). Returning to Work: Barriers and incentives for people with HIV/AIDS. American Psychological Association 108th Annual Meeting. Washington, D.C.

Mellins, C. A., & Ehrhardt, A. A. (1994). Families affected by pediatric acquired immunodeficiency syndrome: sources of stress and coping. Journal of Developmental and Behavioral Pediatrics, 15(3 Suppl), S54–60.PubMed

Miller, I. W., Bishop, D. S., Herman, D. S., & Stein, M. D. (2007). Relationship quality among HIV patients and their caregivers. AIDS Care, 19(2), 203–211.PubMed

Mintz, J., Mintz, L., Arruda, M. J., & Hwang, S. (1992). Treatment of depression and the functional capacity to work. Archives of General Psychiatry, 49, 761–768.PubMed

Mizuno, Y., Purcell, D. W., Dawson-Rose, C., & Parsons, J. T. (2003). Correlates of depressive symptoms among HIV-positive injection drug users: the role of social support. AIDS Care, 15, 689–698.PubMed

Morriss, R. K., Schaerf, F., Brandt, J., & McArthur, J. C. (1992). AIDS and multiple sclerosis: Neural and mental features. Acta Psychiatrica Scandinavica, 85, 331–336.PubMed

Odenheimer, G. L., Beaudet, M., Jette, A. M., Albert, M. S., Grande, L., & Minaker, K. L. (1994). Performance-based driving evaluation of the elderly driver: safety, reliability, and validity. Journal of Gerontology, 49, M153–M159.PubMed

Palepu, A., Horton, N. J., Tibbetts, N., Meli, S., & Samet, J. H. (2004). Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction, 99(3), 361–368.PubMed

Parsons, J. T., Rosof, E., & Mustanski, B. (2007). Patient-related factors predicting HIV medication adherence among men and women with alcohol problems. Journal of Health Psychology, 12(2), 357–370.PubMed

Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133(1), 21–30.PubMed

Perdices, M., Dunbar, N., Grunseit, A., Hall, W., & Cooper, D. A. (1992). Anxiety, depression and HIV related symptomatology across the spectrum of HIV disease. The Australian and New Zealand Journal of Psychiatry, 26, 560–566.PubMed

Pflanz, S., Besson, J. A., Ebmeier, K. P., & Simpson, S. (1991). The clinical manifestation of mental disorder in Huntington’s disease: a retrospective case record study of disease progression. Acta Psychiatrica Scandinavica, 83, 53–60.PubMed

Prachakul, W., & Grant, J. S. (2003). Informal caregivers of persons with HIV/AIDS: a review and analysis. Journal of the Association of Nurses in AIDS Care, 14, 55–71.PubMed

Pugh, R. (1983). An association between hostility and poor adherence to treatment in patients suffering from depression. British Journal of Medical Psychology, 56, 205–208.PubMed

Rabkin, J. G. (1997). Meeting the challenge of depression in HIV. GMHC Treatment Issues, 11, 6–11.PubMed

Rabkin, J. G., & Chesney, M. A. (1998). Adhering to complex regimens for HIV. Gay Men’s Health Crisis: Treatment Issues, 12(4), 8–11.

Rabkin, J. G., Ferrando, S. J., Jacobsberg, L. B., & Fishman, B. (1997). Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Comprehensive Psychiatry, 38(3), 146–154.PubMed

Rabkin, J. G., Ferrando, S. J., van Gorp, W., Rieppi, R., McElhiney, M., & Sewell, M. (2000). Relationships among apathy, depression, and cognitive impairment in HIV/AIDS. Journal of Neuropsychiatry and Clinical Neurosciences, 12(4), 451–457.PubMed

Rabkin, J. G., McElihiney, M., Ferrando, S. J., van Gorp, W. G., & Hsing, S. (2004). Predictors of employment of men with HIV/AIDS: A longitudinal study. Psychosomatic Medicine, 66, 72–78.PubMed

Razzano, L. A., Hamilton, M. M., & Perloff, J. K. (2006). Work status, benefits, and financial resources among people with HIV/AIDS. Work, 27, 235–245.PubMed

Rebok, G. W., Bylsma, F. W., Keyl, P. M., Brandt, J., & Folstein, S. E. (1995). Automobile driving in Huntington’s disease. Movement Disorders, 10, 778–787.PubMed

Reinhard, M. J., Hinkin, C. H., Barclay, T. R., Levine, A. J., Marion, S., Castellon, S. A., et al. (2007). Discrepancies between self-report and objective measures for stimulant drug use in HIV: Cognitive, medication adherence and psychological correlates. Addictive Behavior.

Rizzo, M., Reinach, S., McGehee, D., & Dawson, J. (1997). Simulated car crashes and crash predictors in drivers with Alzheimer Disease. Archives of Neurology, 54, 545–551.PubMed

Sadek, J. R., Vigil, O., Grant, I., & Heaton, R. K. (2007). The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. Journal of Clinical and Experimental Neuropsychology, 29(3), 266–276.

Salthouse, T. A., Atkinson, T. M., & Berish, D. E. (2003). Executive functioning as a potential mediator of age-related cognitive decline in normal adults. Journal of Experimental Psychology (General), 132(4), 566–594.

Satz, P., Myers, H. F., Maj, M., Fawzy, F., Forney, D. L., Bing, E. G., et al. (1997). Depression, substance use and sexual orientation as co-factors in HIV-1 infected men: Cross-cultural comparisons. NIDA Research Monographs, 172, 130–155.

Sensky, T., Leger, C., & Gilmour, S. (1996). Psychosocial and cognitive factors associated with adherence to dietary and fluid restriction regimens by people on chronic haemodialysis. Psychotherapy and Psychosomatics, 65, 36–42.PubMedCrossRef

Shah, G. N., & Mooradian, A. D. (1997). Age-related changes in the blood-brain barrier. Experimental Gerontology, 32(4–5), 501–519.PubMed

Shapiro, P. A., Williams, D., Foray, A., Gelman, I. S., Wukich, N., & Sciacca, R. (1995). Psychosocial evaluation and prediction of compliance problems and morbidity after hearty transplantation. Transplantation, 60, 1462–1466.PubMed

Singh, N., Squier, C., Sivek, C., Wagener, M., Nguyen, M. H., & Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261–269.PubMed

Starkstein, S. E., Fedoroff, J. P., Price, T. R., Leiguarda, R., & Robinson, R. G. (1993). Apathy following cerebrovascular lesions. Stroke, 24, 1625–1630.PubMed

Starkstein, S., Mayberg, H. S., Preziosi, T. J., Andrezejewski, P., Leiguarda, R., & Robinson, R. G. (1992). Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 134–139.PubMed

Stober, D. R., Schwartz, J. A., McDaniel, S. J., & Abrams, R. F. (1997). Depression and HIV disease: prevalence, correlates and treatments. Psychiatric Annals, 27, 372–377.

Suarez, S., Baril, L., Stankoff, B., Khellaf, M., Dubois, B., Lubetzki, C., et al. (2001). Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy. AIDS, 15(2), 195–200.PubMed

Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114(7), 573–580.PubMed

Tyler, D. (2002). Disability and medical management of natural latex sensitivity claims. The Journal of Allergy and Clinical Immunology, 110(Suppl. 2), S129–S136.PubMed

Valcour, V., Shikuma, C., Shiramizu, B., Watters, M., Poff, P., Selnes, O., et al. (2004). Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 Cohort. Neurology, 63(5), 822–827.PubMed

van Gorp, W. (2008). Neuropsychiatric predictors of return to work in HIV infection. Presentation at the American Psychological Association 116th Annual Convention, Boston, Massachusetts.

van Gorp, W., Baerwald, J. P., Ferrando, S., McElhiney, M. C., & Rabkin, J. G. (1999). The relationship between employment and neuropsychological impairment in HIV infection. Journal of the Neuropsychological Society, 5, 534–539.

van Gorp, W., Rabkin, J. G., Ferrando, S. J., Mintz, J., Ryan, E., Borkowski, T., et al. (2007). Neuropsychiatric predictors of return to work in HIV/AIDS. Journal of the International Neuropsychological Society, 13, 80–89.PubMed

van Reekum, R., Stuss, D. T., & Ostrander, L. (2005). Apathy: why care? The Journal of Neuropsychiatry and Clinical Neurosciences, 17(1), 7–19.PubMed

Vitry-Henry, L., Penalba, C., Beguinot, L., & Deschamps, F. (1999). Relationships between work and AIDS status. Occupational Medicine, 49, 115–166.PubMed

Waldrop-Valverde, D., Ownby, R. L., Wilkie, F. L., Mack, A., Kumar, M., & Metsch, L. (2006). Neurocognitive aspects of medication adherence in HIV-positive injecting drug users. AIDS Behavior, 10(3), 287–297.

Weaver, K. E., Llabre, M. M., Duran, R. E., Antoni, M. H., Ironson, G., Penedo, F. J., et al. (2005). A stress and coping model of medication adherence and viral load in HIV-positive men and women on highly active antiretroviral therapy (HAART). Health Psychology, 24(4), 385–392.PubMed

Yasuda, S., Wehman, P., Targett, P., Cifu, D., & West, M. (2001). Return to work for persons with traumatic brain injury. American Journal of Physical Medicine & Rehabilitation, 80(11), 852–864.

Title: Functional Consequences of HIV-Associated Neuropsychological Impairment
Authors: Ashley A. Gorman
Jessica M. Foley
Mark L. Ettenhofer
Charles H. Hinkin
Wilfred G. van Gorp
Publication date: 01-06-2009
Publisher: Springer US
Published in: Neuropsychology Review / Issue 2/2009
Print ISSN: 1040-7308
Electronic ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-009-9095-0

At a glance: The STEP trials

Springer Medicine

Functional Consequences of HIV-Associated Neuropsychological Impairment

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2009

Autism Overflows with Syntheses

Special Section of Neuropsychology Review on HIV/NeuroAIDS

Neuropsychological Assessment of HIV-Infected Populations in International Settings

HIV Infection and the Central Nervous System: A Primer

Race-Norming of Neuropsychological Tests

Autism is a Portmanteau Syndrome